W Douglas Cress Selected Research

HLM006474

1/2014

E2F inhibition synergizes with paclitaxel in lung cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W Douglas Cress Research Topics

Disease

19	Neoplasms (Cancer) 01/2021 - 05/2004
13	Lung Neoplasms (Lung Cancer) 01/2021 - 09/2004
5	Adenocarcinoma of Lung 12/2016 - 11/2012
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 12/2010
2	Melanoma (Melanoma, Malignant) 11/2019 - 01/2011
2	Breast Neoplasms (Breast Cancer) 11/2012 - 01/2011
2	Ovarian Neoplasms (Ovarian Cancer) 01/2011 - 11/2008
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Inflammation (Inflammations) 01/2015
1	Retinoblastoma (Glioblastoma, Retinal) 01/2015
1	Adenocarcinoma 01/2014
1	Osteosarcoma (Osteogenic Sarcoma) 11/2010
1	Hypoxia (Hypoxemia) 07/2008
1	Infections 02/2004
1	Carcinoma (Carcinomatosis) 01/2003

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2003
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2016
4	Phosphotransferases (Kinase)IBA 01/2016 - 02/2004
4	Messenger RNA (mRNA)IBA 01/2015 - 05/2004
4	Pharmaceutical PreparationsIBA 01/2015 - 02/2004
2	CytokinesIBA 11/2019 - 01/2011
2	Cadherins (E-Cadherin)IBA 01/2018 - 01/2014
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2017 - 01/2016
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2017 - 10/2009
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016 - 01/2015
1	p21-Activated KinasesIBA 01/2021
1	Monomeric GTP-Binding ProteinsIBA 01/2021
1	palbociclibIBA 01/2021
1	abemaciclibIBA 01/2021
1	Type I Tumor Necrosis Factor ReceptorsIBA 11/2019
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 11/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2019
1	DNA (Deoxyribonucleic Acid)IBA 12/2017
1	Phenformin (Fenformin)IBA 01/2016
1	adavosertibIBA 01/2016
1	PlatinumIBA 01/2016
1	Platinum Compounds (Compounds, Platinum)IBA 01/2016
1	Estrogen Receptor alphaIBA 10/2015
1	tyrosine receptor (receptor, tyrosine)IBA 10/2015
1	Estrogens (Estrogen)FDA Link 10/2015
1	Niflumic AcidIBA 01/2015
1	ProstaglandinsIBA 01/2015
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2015
1	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 01/2015
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2015
1	PerforinIBA 03/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2014
1	HLM006474IBA 01/2014
1	Taxoids (Taxanes)IBA 01/2014
1	CrizotinibIBA 01/2014
1	Transcription Factors (Transcription Factor)IBA 01/2014
1	Gefitinib (Iressa)FDA Link 01/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2014
1	Tripartite Motif-Containing Protein 28IBA 11/2012
1	Indicators and Reagents (Reagents)IBA 12/2011
1	necdinIBA 01/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2011
1	entinostat (MS 275)IBA 12/2010
1	scriptaidIBA 12/2010
1	Checkpoint Kinase 1IBA 12/2010
1	Histone Deacetylase InhibitorsIBA 12/2010
1	Valproic Acid (Depakote)FDA LinkGeneric 12/2010
1	apicidinIBA 12/2010
1	PanobinostatIBA 12/2010
1	Retinoblastoma ProteinIBA 11/2010
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2008
1	RNA (Ribonucleic Acid)IBA 07/2008
1	Cyclin-Dependent Kinase 2IBA 02/2004
1	Cyclin AIBA 02/2004
1	alvocidib (flavopiridol)IBA 01/2003

Therapy/Procedure

8	Therapeutics 11/2019 - 05/2004
1	Adjuvant Chemotherapy 12/2016
1	Drug Therapy (Chemotherapy) 01/2016